≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Melanoma of uvea

Endpoint Browser PheWeb

CD2_UVEAMELANOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 342 158 184
Unadjusted period prevalence (%) 0.07 0.05 0.08
Median age at first event (years) 64.02 61.76 65.96

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
300
Matched controls
3000
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
323.0
251
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
220.1
230.1
219
36
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
214.1
179
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
212.7
178
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
181.2
155
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
434.1
151.5
140
6
WX140
NOMESCO Finland
Parabulbar anesthesy
65.8
145.1
167
56
XCK10
NOMESCO Finland
Photography of fundus of eye
22.7
111.8
184
195
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
17.4
86.2
152
167
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
19.9
82.1
133
115
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
79.8
73
*
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
80.5
70.7
78
13
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
67.3
62
*
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
60.5
56
*
130
Kela drug reimbursment
Malignant tumour
+∞
59.4
55
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
56.0
52
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
9.7
52.2
121
196
WX002
NOMESCO Finland
Sedation and analgesia
7.5
51.6
155
375
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
12.9
50.0
95
104
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
49.3
46
*
H02AB02
ATC
dexamethasone; systemic
29.2
33.4
45
18
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
32.9
31
*
A04AA02
ATC
granisetron; systemic, transdermal
127.3
32.4
34
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
31.8
30
*
ZXA00
NOMESCO Finland
Right side
4.5
31.2
153
564
ZXA05
NOMESCO Finland
Left side
4.5
30.7
151
556
Z51.5
ICD-10 Finland
Palliative care
19.4
29.5
45
27
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
27.5
26
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
27.5
26
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
26.4
25
*
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
25.4
24
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.4
24.3
81
192
S01ED51
ATC
timolol, combinations; ophthalmic
6.2
23.9
69
137
N02AA05
ATC
oxycodone; systemic
5.2
23.7
83
207
115
Kela drug reimbursment
Breast cancer
+∞
23.2
22
*
JN4BD
NOMESCO Finland
Extensive body CT
8.6
22.3
50
68
CH2S4
NOMESCO Finland
Photography of iris
236.4
21.9
22
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.2
21.5
96
303
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
26.6
21.3
29
12
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
21.1
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
21.1
20
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
20.2
20.9
31
17
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
20.0
19
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
6.5
19.1
52
94
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
18.9
18
*
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
18.9
18
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
18.0
18.2
28
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
17.8
174
958
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
25.9
17.6
24
10
WX142
NOMESCO Finland
Sub-tenon anesthesy
53.3
17.2
20
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
16.4
99
389
3779
FHL
Other operations in this group include disc removal
+∞
15.8
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
15.8
15
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
15.8
15
*
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.8
15
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
89.9
15.7
17
*
L02BG04
ATC
letrozole; oral
168.4
15.6
16
*
CD2S4
NOMESCO Finland
Photography of eye
84.3
14.7
16
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
14.7
14
*
JN4CD
NOMESCO Finland
Very extensive body CT
13.5
14.7
25
20
L01AX03
ATC
temozolomide; systemic
+∞
13.6
13
*
CDC00
NOMESCO Finland
Enucleation of eye
+∞
13.6
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.6
13
*
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
+∞
13.6
13
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.6
13
*
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
146.3
13.6
14
*
A04AA01
ATC
ondansetron; systemic, rectal
11.3
13.5
25
24
116
Kela drug reimbursment
Prostate cancer
+∞
12.6
12
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
12.6
12
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
12.6
12
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
+∞
12.6
12
*
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
12.6
12
*
180
Kela drug reimbursment
Interferon alfa
+∞
12.6
12
*
WF002
NOMESCO Finland
Radical radiotherapy
135.4
12.5
13
*
XCD20
NOMESCO Finland
Photoangiography of eye
8.8
12.3
26
32
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
12.3
158
941
WZC30
NOMESCO Finland
Teaching
4.1
12.2
49
135
H26.2
ICD-10 Finland
Complicated cataract
17.3
11.8
18
11
H33.2
ICD-10 Finland
Serous retinal detachment
67.6
11.7
13
*
S01ED01
ATC
timolol; ophthalmic
5.9
11.6
32
59
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
124.6
11.5
12
*
JN4AD
NOMESCO Finland
Body CT examination
6.6
11.4
29
48
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
36.6
11.4
14
*
A06AH03
ATC
naloxegol; oral
113.8
10.5
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
10.5
10
*
HA1AA
NOMESCO Finland
X-ray mammography
7.5
10.0
23
33
XX3DW
NOMESCO Finland
Time consuming IT work
5.2
9.6
29
60
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
9.5
52
183
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
9.2
89
443
ZXA10
NOMESCO Finland
Bilateral
2.5
8.9
79
377
H33.0
ICD-10 Finland
Retinal detachment with retinal break
7.0
8.8
21
32
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
51.5
8.7
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
20.7
8.5
12
6
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.6
8.5
21
34
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
92.5
8.5
9
*
L03AA02
ATC
filgrastim; parenteral
92.5
8.5
9
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
8.4
8
*
C69.20
ICD-10 Finland
Retina
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.4
8
*
S01EC01
ATC
acetazolamide; systemic
6.0
8.0
21
37
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
8.0
32
89
CA1ME
NOMESCO Finland
Ultrasound oculometry
11.2
7.9
14
13
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.0
7.5
16
21
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.5
7.3
60
270
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
20.6
7.2
10
5
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.0
6.9
129
835
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.5
6.8
15
21
H43.1
ICD-10 Finland
Vitreous haemorrhage
5.7
6.7
18
33
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.1
6.7
14
18
XCH00
NOMESCO Finland
Eye pressure measurement
4.4
6.7
23
56
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
12.6
6.6
11
9
D31.2
ICD-10 Finland
Benign neoplasm: Retina
71.3
6.4
7
*
L02BA01
ATC
tamoxifen; oral
71.3
6.4
7
*
L03AB05
ATC
interferon alfa-2b; parenteral
71.3
6.4
7
*
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
71.3
6.4
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
6.3
6
*
CH3S4
NOMESCO Finland
Photography of iridocorneal angle
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
27.3
6.3
8
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.3
6.3
8
*
114
Kela drug reimbursment
Glaucoma
2.7
6.2
40
159
S01EA03
ATC
apraclonidine; ophthalmic
10.3
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
234
785
7.27
71.52
5.8
2.9
u/l
29.4
34.3
1.48
229
742
(4035726)
56
75
8.73
40.72
1.5
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
23
14
17.54
27.41
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
59
152
4.48
21.48
3.7
1.3
ug/l
9.1
2.8
0.89
47
117
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
18
0
+∞
18.93
1.1
0.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
212
1278
2.73
17.93
10.3
4.1
umol/l
13.6
11.9
0.64
207
1201
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
281
1988
3.32
17.11
14.5
5.4
u/l
90.6
76.3
2.41
271
1819
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
21
27
8.22
15.45
2.0
1.6
u/ml
7.7
139.7
0.46
21
27
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
31
62
5.40
15.09
2.6
1.7
u/ml
19.3
205.6
0.75
26
47
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
0
+∞
14.69
1.1
0.0
%
35.6
—
—
14
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
14
0
+∞
14.69
1.0
0.0
%
8.9
—
—
14
0
(3002256) Pathology report gross observation
54
195
3.10
11.72
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
30
6.65
11.67
1.1
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
206
1399
2.19
11.08
13.6
6.0
e9/l
4.1
4.3
0.53
184
1226
(42870588) Differential panel, method unspecified - Blood
140
833
2.15
10.42
6.6
5.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
132
799
2.06
9.13
2.6
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
125
744
2.07
9.04
2.6
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
190
1313
2.01
9.03
8.5
5.9
mmol/l
1.2
1.2
0.73
153
1120
(40768800) Prostate Pathology biopsy report
13
18
7.47
8.90
1.5
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
169
1131
1.98
8.71
7.0
3.8
g/l
33.9
35.4
2.33
154
1033
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
43
4.62
8.00
4.5
2.7
%
53.1
58.6
0.63
19
43
(3033658) Prothrombin time (PT) actual/Normal
106
617
2.04
7.98
5.4
3.4
%
88.8
87.1
0.29
106
597
(3035637) Corticotropin [Mass/volume] in Plasma
11
15
7.54
7.59
1.5
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
172
1197
1.88
7.53
7.4
5.6
mmol/l
1.2
1.2
0.23
160
1059
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
42
4.47
7.31
3.6
2.3
e9/l
4.2
4.6
0.23
18
42
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
131
850
1.88
7.02
3.0
2.3
u/l
53.2
56.3
0.77
122
781
(3023368) Bacteria identified in Blood by Culture
116
725
1.91
6.97
4.6
4.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
96
573
1.94
6.57
9.3
4.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
130
860
1.83
6.44
6.8
2.1
mmol/l
2.4
2.4
0.01
112
704
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
5
18.43
6.29
6.4
1.0
u/ml
26.2
14.2
—
9
5
(3032080) INR in Blood by Coagulation assay
159
1124
1.77
6.26
7.9
9.1
inr
1.1
1.3
1.95
50
303
(3026782) Osmolality of Urine
87
522
1.89
5.79
2.9
2.6
mosm/kgh2o
475.6
543.3
2.71
80
421
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
154
1099
1.73
5.72
4.3
3.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
205
1608
1.69
5.18
5.8
4.7
mmol/l
6.9
6.9
0.08
193
1498
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
20
66
3.16
5.03
2.6
2.3
mg/l
1.8
1.5
0.57
20
58
(3037121) Protein [Mass/volume] in Urine
23
86
2.80
4.68
4.7
2.2
g/l
0.4
0.3
—
10
26
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
8
10.20
4.54
1.1
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
8
10.20
4.54
4.6
1.5
u/l
208.8
241.8
—
8
8
(3018010) Neutrophils/100 leukocytes in Blood
157
1189
1.59
4.27
7.3
5.4
%
57.9
57.6
0.10
152
1091
(3018418) pH of Serum or Plasma
112
785
1.63
4.17
5.2
3.3
ph
7.4
7.4
0.13
28
124
(3002582) Erythrocytes [#/volume] in Urine
115
813
1.62
4.13
3.1
3.1
e6/l
37.5
135.3
0.63
95
628
(3007853) Bacteria identified in Skin by Aerobe culture
53
301
1.90
4.10
1.9
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
39
199
2.08
4.07
1.5
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
165
1283
1.55
3.89
7.4
5.3
e9/l
2.4
1.9
0.68
145
1127
(3013115) Eosinophils [#/volume] in Blood
168
1312
1.55
3.88
7.4
5.4
e9/l
0.2
0.2
1.07
150
1146
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
245
2751
0.61
3.81
4.9
5.4
mmol/l
2.6
2.7
0.13
229
2501
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
39
206
2.01
3.72
1.5
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
273
1.88
3.70
3.5
3.0
—
—
—
0
0
(3019225) pH of Specimen
46
258
1.90
3.70
6.9
3.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
12
6.79
3.69
2.9
1.5
ug/l
19.2
17.3
—
8
12
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
35
3.52
3.65
1.2
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
162
1268
1.53
3.63
7.4
5.2
e9/l
0.0
0.0
0.00
144
1100
(3003458) Phosphate [Moles/volume] in Serum or Plasma
54
321
1.81
3.62
6.9
5.3
mmol/l
1.1
1.0
1.23
47
285
(3001604) Monocytes [#/volume] in Blood
161
1260
1.52
3.60
7.5
5.2
e9/l
0.6
0.6
0.65
144
1088
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
235
2655
0.63
3.60
4.3
4.8
mmol/l
1.4
1.5
0.84
221
2411
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
227
2583
0.64
3.58
6.2
6.6
mmol/mol
41.2
40.8
0.24
211
2383
(3003434) Protein [Mass/volume] in Pleural fluid
10
26
3.93
3.54
1.8
1.2
g/l
36.8
26.3
—
10
21
(3018095) Leukocytes [#/volume] in Urine
127
948
1.54
3.52
3.7
3.6
e6/l
95.9
105.7
0.10
98
676
(3042936) Bacteria identified in Isolate by Culture
60
373
1.74
3.46
2.2
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
227
2575
0.65
3.40
3.9
4.3
mmol/l
1.4
1.3
1.29
213
2320
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
239
2679
0.64
3.34
4.5
4.8
mmol/l
4.5
4.5
0.35
222
2445
(40761536) Microorganisms panel - Urine sediment
37
203
1.92
3.18
4.2
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
83
574
1.59
3.17
2.7
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
55
347
1.70
3.01
3.2
2.3
%
20.8
23.2
0.92
49
303
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
125
956
1.48
2.99
4.0
3.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
17
4.79
2.93
2.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
62
899
0.62
2.91
3.1
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
95
691
1.52
2.88
3.3
2.8
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
13
5.47
2.88
1.7
1.1
u/l
179.1
345.3
—
7
13
(3000850) Epithelial cells [#/volume] in Urine
81
571
1.55
2.83
2.6
2.5
e6/l
4.2
5.1
0.48
74
485
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
53
2.71
2.83
1.8
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
9
23
3.99
2.79
1.1
1.7
mosm/kgh2o
290.0
269.8
—
9
16
(3030467) Casts [#/volume] in Urine by Automated count
98
732
1.47
2.59
3.4
2.9
e6/l
0.6
0.5
0.13
83
541
(3045788) Cell count panel - Pleural fluid
7
16
4.44
2.48
1.9
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
13
4.68
2.28
1.3
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
283
1.64
2.25
4.5
2.4
umol/l
13.9
7.6
0.56
37
245
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
247
2694
0.70
2.19
5.0
4.9
mmol/l
6.2
6.1
0.43
226
2412
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
31
2.95
2.08
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
20
3.55
2.06
1.6
1.2
—
—
—
0
0
(4062490)
7
20
3.55
2.06
1.3
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
11
4.59
1.95
1.0
2.1
nmol/l
3.4
4.8
—
5
11
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
284
2632
1.47
1.91
23.0
13.7
mg/l
27.6
23.9
0.94
246
2044
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
184
0.42
1.87
1.4
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
152
1287
1.33
1.80
3.6
3.8
estimate
0.0
0.0
0.00
38
207
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
30
2.71
1.73
3.5
1.8
pg
34.3
33.6
—
8
30
(3026008) Bacteria identified in Urine by Culture
103
828
1.35
1.72
3.0
3.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
48
2.33
1.72
1.6
1.3
—
—
—
0
0
(4281824)
5
13
3.89
1.72
1.4
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
445
0.62
1.69
1.2
1.3
u/ml
42.9
8.9
0.75
12
164
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
83
1.97
1.67
2.2
3.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
463
0.64
1.61
1.2
1.3
iu/ml
57.2
38.3
0.39
13
151
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
283
0.54
1.60
2.3
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
26
2.73
1.59
2.3
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
205
1831
1.30
1.57
5.4
4.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
75
583
1.37
1.55
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
170
1.64
1.54
2.4
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
69
530
1.38
1.53
5.6
2.1
mmol/l
2.5
2.4
2.02
59
448
(3022145) Colonoscopy Study observation
36
244
1.53
1.52
1.3
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
20
116
1.77
1.52
8.3
4.5
mmol/l
25.9
25.0
0.30
20
109
(3027945) Reticulocytes/100 erythrocytes in Blood
46
334
1.44
1.41
3.1
2.2
%
1.8
1.7
0.27
41
291
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
41
2.23
1.38
4.1
2.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
176
1.58
1.36
6.9
3.9
mmol/l
2.4
2.2
0.04
21
129
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
442
1.38
1.35
1.8
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
37
0.00
1.35
0.0
1.1
—
4.9
—
0
17
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
38
0.00
1.35
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
47
2.16
1.35
6.4
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
28
186
1.55
1.31
6.8
3.8
ph
7.4
7.4
—
5
20
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
55
418
1.38
1.31
2.9
2.8
e6/l
0.8
3.0
2.92
32
225
(4024509)
5
18
2.80
1.29
2.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
179
1.55
1.28
3.7
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
298
2835
1.40
1.27
18.1
9.3
u/l
28.3
25.4
1.95
289
2708
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
182
1629
1.25
1.25
4.3
3.1
u/l
90.7
48.2
2.27
172
1493
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
13
70
1.89
1.25
4.7
1.2
mg/l
19.4
33.6
—
6
59
(3034860) Kappa light chains.free [Mass/volume] in Serum
13
70
1.89
1.25
4.8
1.2
mg/l
27.5
47.9
—
6
58
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
230
2471
0.79
1.24
5.2
4.6
mu/l
1.9
2.0
0.60
213
2212
(3041096) Erythrocytes [Presence] in Urine by Automated
85
696
1.29
1.23
3.5
3.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
78
1.83
1.23
3.2
2.7
u/ml
0.3
0.4
—
8
43
(3021960) Folate [Moles/volume] in Serum or Plasma
59
744
0.75
1.21
1.9
1.5
nmol/l
20.8
21.4
0.13
54
627
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
232
1.47
1.21
1.6
1.9
%
2.0
1.7
0.58
27
200
(3029937) Albumin [Presence] in Urine by Test strip
84
691
1.29
1.17
3.5
4.1
estimate
0.0
0.0
0.50
33
206
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
33
0.00
1.16
0.0
1.1
—
1.3
—
0
13
(4306422)
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
167
1.54
1.16
1.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
20
2.52
1.15
5.0
3.3
—
—
—
0
0
(3015736) pH of Urine
120
1033
1.25
1.15
3.3
3.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
129
1122
1.24
1.12
14.1
8.1
e9/l
0.0
0.0
0.72
112
926
(1616796) Gas panel - Central venous blood
10
51
1.99
1.12
6.3
2.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
41
1.97
1.09
1.1
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
21
2.40
1.09
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
108
1248
0.80
1.09
2.4
2.1
pmol/l
98.3
94.0
0.33
59
631
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
33
2.14
1.06
1.3
2.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
138
1.56
1.05
7.5
3.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
22
2.29
1.03
8.0
2.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
22
2.29
1.03
2.8
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
36
268
1.38
0.99
2.8
3.5
mmol/l
1.4
2.1
0.62
28
218
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
54
1.88
0.97
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
31
0.00
0.97
0.0
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
77
1.72
0.96
1.4
1.2
—
—
—
0
0
(3013512) EKG study
101
874
1.22
0.90
4.2
4.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
10
56
1.81
0.88
7.4
2.7
mmol/l
1.4
2.9
—
5
32
(3014576) Chloride [Moles/volume] in Serum or Plasma
44
346
1.31
0.87
6.6
5.4
mmol/l
104.5
104.1
0.28
44
335
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
45
1.80
0.85
1.1
2.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
35
268
1.34
0.83
2.6
3.5
kpa
5.6
5.8
0.57
35
259
(3002179) Metamyelocytes/100 leukocytes in Blood
23
164
1.43
0.82
8.4
4.1
%
0.7
0.2
—
9
30
(3021601) Nitrite [Presence] in Urine by Test strip
144
1300
1.19
0.81
4.9
5.2
estimate
0.0
0.0
0.00
36
202
(1002224) Polysomnography panel
5
96
0.51
0.79
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
174
1.41
0.79
7.9
4.0
%
0.0
0.1
0.80
11
38
(4268621)
0
26
0.00
0.78
0.0
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
27
0.00
0.77
0.0
1.0
—
282.2
—
0
20
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
27
0.00
0.77
0.0
1.0
—
40.7
—
0
19
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
27
0.00
0.77
0.0
1.0
—
596.3
—
0
20
(4034850)
16
107
1.52
0.77
17.6
12.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
25
184
1.39
0.76
8.0
3.9
%
0.5
0.7
0.18
11
41
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
128
1151
1.18
0.75
4.2
3.9
ng/l
34.2
67.8
0.60
96
851
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.10
0.75
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
100
1.52
0.74
1.9
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
145
1319
1.17
0.73
3.7
3.8
estimate
0.0
0.0
0.50
38
203
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
375
0.75
0.73
8.6
7.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
56
1.62
0.73
1.2
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
10
158
0.62
0.72
1.7
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
275
1.30
0.72
2.0
3.5
ng/l
269.2
241.4
0.10
29
254
(3026493) Urate [Moles/volume] in Serum or Plasma
83
722
1.20
0.70
3.3
2.4
umol/l
5522.2
7629.8
0.15
70
623
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
117
0.59
0.69
1.6
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
21
153
1.40
0.69
1.5
3.2
mmol/l
24.6
25.4
0.65
21
148
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
131
0.60
0.64
1.6
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
317
1.26
0.63
1.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
318
1.26
0.62
1.3
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
105
1.45
0.61
2.5
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
29
228
1.30
0.61
2.1
2.9
kpa
4.4
4.4
0.01
29
218
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(4027681)
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.3
—
90.6
—
0
5
(3045414) Leukocytes [Presence] in Urine
15
106
1.43
0.58
1.9
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
111
1005
1.15
0.58
3.8
4.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
1.0
—
0
14
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
191
2019
0.88
0.56
4.5
3.7
pmol/l
15.0
15.0
0.19
176
1795
(3012516) Albumin [Mass/volume] in Urine
84
939
0.86
0.55
3.8
3.3
mg/l
101.8
191.5
0.41
63
582
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
134
1.36
0.54
13.5
12.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
447
1.19
0.52
3.0
2.6
e6/l
1.0
1.1
0.03
30
254
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
80
890
0.87
0.50
5.0
3.8
%
21.8
24.8
1.20
44
421
(3009508) Creatinine [Moles/volume] in Urine
87
962
0.87
0.49
3.7
3.2
mmol/l
7.4
7.6
0.09
73
790
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
63
555
1.17
0.48
1.9
1.8
mg/l
1.2
1.2
0.06
51
431
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
58
659
0.86
0.48
1.7
1.7
pmol/l
505.5
18267856.0
0.79
51
531
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
118
0.67
0.46
1.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
49
1.44
0.46
1.4
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
210
2193
0.89
0.46
25.5
18.3
g/l
331.1
332.1
0.85
205
2177
(3022217) INR in Platelet poor plasma by Coagulation assay
50
434
1.18
0.45
17.9
25.9
inr
1.5
1.3
—
7
65
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
31
1.62
0.43
2.0
3.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
167
1.27
0.43
8.0
4.1
%
0.0
0.0
0.49
11
34
(3014051) Protein [Presence] in Urine by Test strip
8
57
1.41
0.42
1.8
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
32
1.57
0.42
3.0
1.5
%
92.1
90.2
—
5
32
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
58
1.39
0.42
5.1
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
84
920
0.88
0.41
2.4
2.1
u/l
239.3
221.4
0.07
78
853
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
68
610
1.14
0.41
4.0
4.0
ng/l
539.6
280.6
0.23
56
503
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.6
—
30.7
—
0
12
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.6
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(3010421) pH of Blood
10
73
1.38
0.35
8.1
2.9
ph
7.4
7.4
—
10
55
(3052851) Hemolysis interference index of Serum or Plasma
10
73
1.38
0.35
7.4
3.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
45
1.34
0.34
1.5
1.6
mu/l
312.8
270.4
—
6
39
(3017732) Neutrophils [#/volume] in Blood
21
173
1.23
0.33
2.5
2.8
e9/l
4.2
4.0
0.18
15
121
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
76
697
1.12
0.33
2.3
2.2
mg/l
3.3
3.0
0.36
70
579
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
37
323
1.16
0.33
8.0
7.8
kpa
5.2
5.2
0.11
32
314
(3003396) Base excess in Arterial blood by calculation
37
323
1.16
0.33
7.9
7.8
mmol/l
1.5
1.6
0.09
28
250
(36660697) Celiac disease serology panel - Serum
14
176
0.79
0.33
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
176
0.79
0.33
1.2
1.4
—
35.9
—
0
10
(3049717) Cytology report of Urine Cyto stain
12
92
1.32
0.32
2.8
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
20
165
1.23
0.32
1.9
3.0
e6/l
0.4
0.2
0.32
20
159
(40760892) CBC W Ordered Manual Differential panel - Blood
60
545
1.12
0.31
8.9
4.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
96
0.72
0.31
4.4
3.5
mmol/l
4.0
3.9
—
7
88
(3021901) Oxygen saturation in Capillary blood
7
53
1.33
0.31
2.3
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
260
1.17
0.30
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
93
994
0.91
0.30
4.4
4.0
mg/mmol
19.0
6.9
1.15
70
614
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
56
1.26
0.29
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
56
1.26
0.29
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
25
214
1.18
0.28
2.3
2.1
ml/min/173m2
49.7
61.2
—
9
92
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
129
0.77
0.28
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
101
949
1.09
0.28
3.4
3.1
ng/l
1088.5
1558.0
1.31
93
808
(3013707) Erythrocyte sedimentation rate by Westergren method
195
2016
0.92
0.28
4.8
4.2
mm/h
16.1
12.5
1.83
182
1825
(3037522) Nuclear Ab [Titer] in Serum
37
329
1.14
0.27
1.4
1.3
titre
1413.3
559.6
—
6
93
(3000492) Spirometry study
24
206
1.18
0.27
1.9
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
12
95
1.27
0.26
1.4
1.8
—
124.0
—
0
5
(3028626) Oxygen [Partial pressure] in Capillary blood
8
67
1.20
0.26
2.8
2.2
kpa
8.2
7.8
—
8
59
(3009542) Hematocrit [Volume Fraction] of Blood
226
2316
0.93
0.24
21.9
15.1
%
38.8
39.6
0.53
151
1526
(3023103) Potassium [Moles/volume] in Serum or Plasma
287
2824
1.10
0.24
24.7
16.9
mmol/l
4.0
4.0
0.80
278
2743
(3019550) Sodium [Moles/volume] in Serum or Plasma
286
2814
1.10
0.23
24.6
16.8
mmol/l
139.6
139.8
0.45
279
2732
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
3.2
3.9
umol/l
262.0
360.6
—
5
33
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
115
1096
1.07
0.23
2.4
2.3
nmol/l
77.7
78.2
0.07
104
959
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
39
1.29
0.23
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
189
0.84
0.23
2.8
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
129
1346
0.93
0.23
2.3
2.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
79
1.27
0.22
1.3
1.8
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
154
1.18
0.21
1.4
2.5
%
1.4
1.2
0.40
18
154
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
273.8
—
0
6
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
11
0.00
0.21
0.0
1.1
—
4.0
—
0
6
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
9.4
—
0
10
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.6
—
55.9
—
0
10
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
166
0.84
0.21
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
117
1.20
0.21
1.6
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
155
1.17
0.20
4.1
3.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.20
1.5
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
67
630
1.08
0.19
1.9
1.8
nmol/l
1219.5
1211.4
0.03
59
466
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
110
1.19
0.17
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
120
1.17
0.16
1.2
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
279
2754
1.07
0.16
19.7
13.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
71
1.13
0.16
2.0
1.7
—
—
—
0
0
(4094501)
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
295
2919
1.08
0.15
31.7
19.8
e9/l
241.6
243.2
0.13
287
2848
(3035941) MCH [Entitic mass]
295
2919
1.08
0.15
31.5
19.8
pg
30.3
30.4
0.35
289
2870
(3024731) MCV [Entitic volume]
295
2919
1.08
0.15
31.5
19.8
fl
91.6
91.5
0.25
289
2870
(3036489) Thrombin time
7
86
0.81
0.14
2.1
2.1
s
22.1
21.1
—
7
78
(3010813) Leukocytes [#/volume] in Blood
295
2920
1.07
0.14
31.7
19.9
e9/l
7.3
6.7
1.61
288
2838
(3026361) Erythrocytes [#/volume] in Blood
295
2920
1.07
0.14
31.6
19.9
e12/l
4.4
4.5
2.11
287
2837
(3000963) Hemoglobin [Mass/volume] in Blood
295
2921
1.07
0.14
31.8
20.0
g/l
132.2
136.0
3.98
290
2869
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
116
0.86
0.12
2.6
2.2
ug/l
2068.6
311.9
—
10
104
(3044889) 12 lead EKG panel
192
1952
0.96
0.11
4.0
4.0
—
—
—
0
0
(4010399)
19
208
0.91
0.10
1.4
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
165
1.10
0.09
1.4
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
107
1.13
0.08
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
65
0.77
0.08
1.0
2.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
59
610
0.96
0.07
3.4
2.7
ug/l
0.7
0.8
0.32
43
413
(3020891) Body temperature
13
118
1.11
0.07
4.2
3.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
47
453
1.04
0.06
2.5
1.2
g/l
2.2
2.7
1.13
25
255
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
138
1.09
0.06
1.1
1.2
iu/ml
63.6
116.6
—
5
51
(3019832) Treponema pallidum Ab [Presence] in Serum
9
102
0.88
0.06
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
103
0.87
0.06
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
13
141
0.92
0.05
1.1
1.1
u/ml
48.1
199.0
2.96
13
132
(40768797) Stomach Pathology biopsy report
36
374
0.96
0.05
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
91
1.10
0.04
6.0
4.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
160
0.93
0.04
2.0
2.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
24
231
1.04
0.03
9.2
6.0
mmol/l
1.6
1.4
0.31
24
222
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
252
2510
1.02
0.02
21.3
12.4
ml/min/173m2
75.1
75.5
0.12
219
2024
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
111
1100
1.01
0.02
5.5
3.9
ug/l
4.0
2.1
0.52
99
972
(3000991) Gas panel - Venous blood
22
213
1.04
0.01
11.3
7.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
51
517
0.98
0.01
1.3
1.2
u/ml
0.4
1.4
—
10
131
(3011397) Hemoglobin [Presence] in Urine by Test strip
62
626
0.99
0.00
3.3
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
30
301
1.00
0.00
1.4
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
371
1.00
0.00
4.9
4.9
%
32.1
31.8
0.07
28
234
(3019060) Gas panel - Arterial blood
20
197
1.02
0.00
4.7
6.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
303
0.99
0.00
1.2
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
62
617
1.01
0.00
3.4
4.2
kg/l
1.0
1.0
0.03
11
104
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
255
0.98
0.00
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
234
0.98
0.00
6.3
3.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
13.7
—
0
5
(3035285) Chloride [Moles/volume] in Venous blood
5
53
0.94
0.00
2.2
2.4
mmol/l
106.0
105.1
—
5
53
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
2.1
—
1.2
—
0
8
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
17.8
—
0
7
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
51.3
—
0
8
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
52
0.96
0.00
2.2
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
67.0
—
0
6
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
88
0.91
0.00
1.8
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
59
1.02
0.00
1.2
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
4.2
—
109.4
—
0
5
(3041354) Potassium [Moles/volume] in Venous blood
5
53
0.94
0.00
2.2
2.4
mmol/l
4.1
4.1
—
5
53
(3021788) Differential panel - Synovial fluid
5
57
0.88
0.00
1.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
10.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
50
1.00
0.00
1.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_UVEAMELANOMA_EXALLC – Melanoma of uvea

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).